Daily Retinol Use Is a Finished-Formula Question
A brand's daily-use message, a separate tolerance study and product-stability data answer different questions. A finished retinol formula needs evidence for the conditions in which it will be used.
A daily-use message is a product claim
In March 2026, OLAY described its upgraded Regenerist Retinol24 Night Cream as gentle enough for daily use. That is the brand’s statement about its own product. It should not be read as proof that every retinol formula—or every person—can follow the same schedule. [1]
A separate 2022 paper compared specified 0.3% and 1% retinol formulations. Five volunteers took part in a short occlusive patch-and-biopsy experiment; another 218 participants entered a six-week use study that gradually increased facial application to nightly use. In that study, the 0.3% formulation was better tolerated than the 1% formulation. The result belongs to those formulas and that regimen, not to OLAY’s 2026 cream. [2]
The amount in the jar can change
A stability study measured retinoids in 12 commercial cosmetics. Across the tested products, retinoid content fell by 0–80% after six months at 25°C; losses were greater in the study’s 40°C condition, and light was also an important stress. The wide range is the point: an ingredient percentage at manufacture does not tell a team how much remains under every storage condition. The study did not test OLAY’s upgraded product. [3]
European Union Regulation 2024/996 also sets limits for retinol, retinyl acetate and retinyl palmitate in cosmetic products, expressed as retinol equivalents. Regulatory compliance, chemical stability and user tolerability each need their own check. None can be inferred from a concentration printed on the front of a pack. [4]
Test the formula people will actually use
For a new retinol product, the development question is not simply which concentration sounds stronger. It is whether the intended formula retains its active content, remains acceptable under the proposed use schedule, and supports the claims made for that product. Release behavior may be another formulation variable, but it must be measured in the actual system rather than assumed from an ingredient or carrier name.
Sources
- OLAY. OLAY Unveils Newly Upgraded Regenerist Retinol24 Night Cream. March 9, 2026.
- Mellody KT, et al. Multifaceted amelioration of cutaneous photoageing by (0.3%) retinol. International Journal of Cosmetic Science. 2022;44:625–635.
- Temova Rakuša Ž, et al. Retinoid stability and degradation kinetics in commercial cosmetic products. Journal of Cosmetic Dermatology. 2021;20:2350–2358.
- European Commission. Commission Regulation (EU) 2024/996. Official Journal of the European Union. 2024.